InvestorsHub Logo
Followers 33
Posts 7559
Boards Moderated 0
Alias Born 12/15/2002

Re: StockLogistics post# 5192

Monday, 08/22/2022 9:38:08 AM

Monday, August 22, 2022 9:38:08 AM

Post# of 6001
In 2023 the Company plans to continue research activity demonstrating the safety and tolerability of the infant formula as well as provide scientific support for Else products including preparation for additional clinical studies.“

Research, scientific support, clinical studies ... How about MARKETING so mothers find out that we exist and have a great offering for their babies NOW.

All our CEO cares about is scientific topics and she seems happy with minimum sales in a huge market,

The message the institutional investors and market tell her (us) is that (unless you are serious about growing the company, we will wait and see'.

Patiently,

Roger